Review of Multimodality Management of Anaplastic Thyroid Cancer
NCT00280852 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5
Last updated 2011-11-21
Summary
To describe the outcome of patients with anaplastic thyroid cancer treated with hyperfractionated radiotherapy and concomitant chemotherapy
Conditions
- Anaplastic Thyroid Cancer
Sponsors & Collaborators
-
Alberta Health services
lead OTHER
Principal Investigators
-
Harold Lau, MD · Alberta Cancerboard
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-01-31
- Primary Completion
- 2006-06-30
- Completion
- 2006-06-30
Countries
- Canada
Study Locations
More Related Trials
-
Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer
NCT04948437 ·Status: ACTIVE_NOT_RECRUITING
-
COACH - Comparing Two Different Methods to Suppress Thyrotropin in Patients With Advanced Thyroid Cancer
NCT06790589 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Thyroid Cancer in United Arab Emirates
NCT04763122 ·Status: COMPLETED
-
Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases
NCT04411290 ·Status: UNKNOWN
-
HRQOL in Locally Advanced Thyroid Carcinoma
NCT05824312 ·Status: RECRUITING
-
To Study the Impact of Radiation Treatment After Surgery in Patient With Locally Advanced Thyroid Cancer.
NCT03669432 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer
NCT02418247 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
The Initial Management in Patients With Differentiated Thyroid Cancer in the Real World in China
NCT04857086 ·Status: UNKNOWN
-
Studies on Tumors of the Thyroid
NCT00001160 ·Status: RECRUITING
-
Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma
NCT06087068 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma
NCT06860971 ·Status: RECRUITING ·Phase: PHASE3
-
High Dose vs Low Dose I 131 +/- rhTSH for Differentiated Thyroid Cancer
NCT00415233 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Impact of Conventional Treatments and Clinical Variables on Thyroid Cancer
NCT05752604 ·Status: RECRUITING
-
Levothyroxine Treatment for Subclinical Hypothyroidism After Head and Neck Surgery
NCT02548715 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer
NCT00094055 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Prevalence of Osteo-metabolic Complications in Patients With Thyroid Cancer
NCT06627998 ·Status: RECRUITING
-
Differentiated Thyroid Cancer Patients Treated With Different Doses of Radioactive Iodine.
NCT06134830 ·Status: NOT_YET_RECRUITING
-
Medico-Economic Comparison of Four Strategies of Radioiodine Ablation in Thyroid Carcinoma Patients
NCT00435851 ·Status: UNKNOWN ·Phase: PHASE3
-
Differentiation of Benign From Malignant Thyroid Nodules Using Diffuse Reflectance Spectroscopy
NCT07124065 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Anlotinib Hydrochloride Capsules in the Treatment of Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma
NCT05994365 ·Status: RECRUITING
-
Image-guided Thermal Ablation vs. Lobectomy for Solitary Papillary Thyroid Microcarcinoma
NCT06325787 ·Status: COMPLETED ·Phase: NA
-
A Retrospective Observational Study Comparing Two Different Treatment Options in Thyroid Cancer Patients With T4 Tumours
NCT01736163 ·Status: COMPLETED
-
Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer
NCT00389441 ·Status: COMPLETED ·Phase: PHASE2
-
Use of an In Vivo Optical Probe to Discriminate Benign From Malignant Thyroid Nodules
NCT01401855 ·Status: COMPLETED
-
The Incidence and Risk Factors of Radiotherapy Induced Hypothyroidism in Head and Neck Cancer With Long Term Follow up
NCT03699098 ·Status: COMPLETED ·Phase: NA